Loss of normal huntingtin function: new developments in Huntington's disease research

被引:290
|
作者
Cattaneo, E
Rigamonti, D
Goffredo, D
Zuccato, C
Squitieri, F
Sipione, S
机构
[1] Univ Milan, Inst Pharmacol Sci, I-20133 Milan, Italy
[2] IRCCS, Neurogenet Unit, Pozzilli, Isernia, Italy
关键词
D O I
10.1016/S0166-2236(00)01721-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease is characterized by a loss of brain striatal neurons that occurs as a consequence of an expansion of a CAG repeat in the huntingtin protein. The resulting extended polyglutamine stretch confers a deleterious gain-of-function to the protein. Analysis of the mutant protein has attracted most of the research activity in the field, however re-examination of earlier data and new results on the beneficial functions of normal huntingtin indicate that loss of the normal protein function might actually equally contribute to the pathology. Thus, complete elucidation of the physiological role(s) of huntingtin and its mode of action are essential and could lead to new therapeutic approaches.
引用
收藏
页码:182 / 188
页数:7
相关论文
共 50 条
  • [21] Huntingtin protein: A new option for fixing the Huntington's disease countdown clock
    Caterino, Marco
    Squillaro, Tiziana
    Montesarchio, Daniela
    Giordano, Antonio
    Giancola, Concetta
    Melone, Mariarosa A. B.
    NEUROPHARMACOLOGY, 2018, 135 : 126 - 138
  • [22] Huntington disease: new insights on the role of huntingtin cleavage
    Wellington, CL
    Leavitt, BR
    Hayden, MR
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2000, (58): : 1 - 17
  • [23] Huntingtin-lowering strategies for Huntington's disease
    Barker, Roger A.
    Fujimaki, Motoki
    Rogers, Priya
    Rubinsztein, David C.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (10) : 1125 - 1132
  • [24] Huntington's disease: Huntingtin and the control of axonal transport
    Zala, D.
    Liot, G.
    Humbert, S.
    Saudou, F.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 60 - 60
  • [25] Huntington disease: new insights on the role of huntingtin cleavage
    Wellington, CL
    Leavitt, BR
    Hayden, MR
    ADVANCES IN RESEARCH ON NEURODEGENERATION, VOL 7, 2000, 7 : 1 - 17
  • [26] Huntingtin Lowering Strategies for Disease Modification in Huntington's Disease
    Tabrizi, Sarah J.
    Ghosh, Rhia
    Leavitt, Blair R.
    NEURON, 2019, 101 (05) : 801 - 819
  • [27] Targeting Huntingtin in Patients with Huntington's Disease Reply
    Tabrizi, Sarah J.
    Smith, Anne V.
    Bennett, C. Frank
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12): : 1181 - 1182
  • [28] Role of wild type huntingtin in Huntington's disease
    Cattaneo, E
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [29] SUMO modification of Huntingtin and Huntington's disease pathology
    Steffan, JS
    Agrawal, N
    Pallos, J
    Rockabrand, E
    Trotman, LC
    Slepko, N
    Illes, K
    Lukacsovich, T
    Zhu, YZ
    Cattaneo, E
    Pandolfi, PP
    Thompson, LM
    Marsh, JL
    SCIENCE, 2004, 304 (5667) : 100 - 104
  • [30] Targeting Huntingtin Expression in Patients with Huntington's Disease
    Tabrizi, Sarah J.
    Leavitt, Blair R.
    Landwehrmeyer, G. Bernhard
    Wild, Edward J.
    Saft, Carsten
    Barker, Roger A.
    Blair, Nick F.
    Craufurd, David
    Priller, Josef
    Rickards, Hugh
    Rosser, Anne
    Kordasiewicz, Holly B.
    Czech, Christian
    Swayze, Eric E.
    Norris, Daniel A.
    Baumann, Tiffany
    Gerlach, Irene
    Schobel, Scott A.
    Paz, Erika
    Smith, Anne V.
    Bennett, C. Frank
    Lane, Roger M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2307 - 2316